Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP30 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.80e-19	114	105	16	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP30 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.56e-18	124	105	16	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP30 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.83e-17	137	105	16	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP30 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.21e-15	192	105	16	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP30 USP17L23 USP17L12 TMPRSS13 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 ADAMTS12 ADAMTS7 USP17L17 USP17L6P LTF USP17L22 USP17L15 PCSK9 USP17L13	2.33e-11	654	105	21	GO:0008233
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRIK3 GRM2 GRM3	1.16e-05	9	105	3	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRIK3 GRM2 GRM3	1.16e-05	9	105	3	GO:0001640
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	TET2 KDM5C KDM5D TET1 KDM6A	2.35e-05	65	105	5	GO:0016706
GeneOntologyMolecularFunction	group II metabotropic glutamate receptor activity	GRM2 GRM3	2.74e-05	2	105	2	GO:0001641
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET2 TET1	8.19e-05	3	105	2	GO:0070579
GeneOntologyMolecularFunction	dioxygenase activity	TET2 KDM5C KDM5D TET1 KDM6A	1.68e-04	98	105	5	GO:0051213
GeneOntologyMolecularFunction	cytoskeletal anchor activity	ANK1 ANK3 OBSL1	2.64e-04	24	105	3	GO:0008093
GeneOntologyMolecularFunction	glutamate receptor activity	GRIK3 GRM2 GRM3	3.77e-04	27	105	3	GO:0008066
GeneOntologyMolecularFunction	microfibril binding	POLR2A LTBP1	4.05e-04	6	105	2	GO:0050436
GeneOntologyMolecularFunction	histone H3K4me/H3K4me2/H3K4me3 demethylase activity	KDM5C KDM5D	4.05e-04	6	105	2	GO:0034647
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM5C KDM5D KDM6A	4.21e-04	28	105	3	GO:0141052
GeneOntologyMolecularFunction	hyaluronic acid binding	USP17L24 ACAN USP17L6P	4.67e-04	29	105	3	GO:0005540
GeneOntologyMolecularFunction	histone demethylase activity	KDM5C KDM5D KDM6A	5.71e-04	31	105	3	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	KDM5C KDM5D KDM6A	6.27e-04	32	105	3	GO:0140457
GeneOntologyMolecularFunction	histone H3K4 demethylase activity	KDM5C KDM5D	7.51e-04	8	105	2	GO:0032453
GeneOntologyMolecularFunction	demethylase activity	KDM5C KDM5D KDM6A	1.60e-03	44	105	3	GO:0032451
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	RNLS LOXL4	3.13e-03	16	105	2	GO:0016641
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.11e-17	125	105	15	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	7.06e-16	144	105	15	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	DCAF15 USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 UBR5 USP17L6P USP17L22 USP17L15 WDR24 USP17L13	3.15e-06	1009	105	18	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	DCAF15 USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 UBR5 USP17L6P USP17L22 USP17L15 WDR24 USP17L13	7.46e-06	1074	105	18	GO:0043687
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	GRIK3 GRM2 GRM3	1.05e-05	9	105	3	GO:0007196
GeneOntologyBiologicalProcess	collagen fibril organization	SELENON ADAMTS12 ADAMTS7 ACAN LOXL4	4.31e-05	76	105	5	GO:0030199
GeneOntologyBiologicalProcess	G protein-coupled glutamate receptor signaling pathway	GRIK3 GRM2 GRM3	6.84e-05	16	105	3	GO:0007216
GeneOntologyCellularComponent	postsynaptic membrane	ANK1 ANK3 GRIK3 CLSTN2 GRM2 CSMD2 GRM3 SHISA9 CELSR3 FARP1 AFDN	8.08e-06	405	108	11	GO:0045211
GeneOntologyCellularComponent	synaptic membrane	ANK1 ANK3 GRIK3 CLSTN2 GRM2 CSMD2 GRM3 SHISA9 CELSR3 FARP1 AFDN HTT	4.83e-05	583	108	12	GO:0097060
GeneOntologyCellularComponent	somatodendritic compartment	FLNB PSD ANK3 ANKS1B GRIK3 CLSTN2 GRM2 GRM3 SHISA9 ACSL4 ACAN FARP1 LRP2 AFDN LTBP1 FUBP3 HTT CKMT1A	5.53e-05	1228	108	18	GO:0036477
GeneOntologyCellularComponent	postsynaptic density	PSD ANK3 ANKS1B GRIK3 CLSTN2 CSMD2 GRM3 SHISA9 CELSR3 AFDN	1.16e-04	451	108	10	GO:0014069
GeneOntologyCellularComponent	postsynaptic density membrane	GRIK3 CLSTN2 CSMD2 SHISA9 CELSR3 AFDN	1.66e-04	157	108	6	GO:0098839
GeneOntologyCellularComponent	asymmetric synapse	PSD ANK3 ANKS1B GRIK3 CLSTN2 CSMD2 GRM3 SHISA9 CELSR3 AFDN	1.83e-04	477	108	10	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	PSD ANK3 ANKS1B GRIK3 CLSTN2 CSMD2 GRM3 SHISA9 CELSR3 AFDN	2.80e-04	503	108	10	GO:0099572
GeneOntologyCellularComponent	endoplasmic reticulum membrane	ATP8B3 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 CLSTN2 USP17L19 SELENON USP17L18 ACSL4 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.32e-04	1293	108	17	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	ATP8B3 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 CLSTN2 USP17L19 SELENON USP17L18 ACSL4 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.51e-04	1299	108	17	GO:0098827
GeneOntologyCellularComponent	neuron to neuron synapse	PSD ANK3 ANKS1B GRIK3 CLSTN2 CSMD2 GRM3 SHISA9 CELSR3 AFDN	3.81e-04	523	108	10	GO:0098984
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	ATP8B3 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 CLSTN2 USP17L19 SELENON USP17L18 ACSL4 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.48e-04	1327	108	17	GO:0042175
GeneOntologyCellularComponent	dendrite	PSD ANK3 ANKS1B GRIK3 CLSTN2 GRM2 GRM3 SHISA9 FARP1 LRP2 LTBP1 FUBP3 HTT	4.82e-04	858	108	13	GO:0030425
GeneOntologyCellularComponent	dendritic tree	PSD ANK3 ANKS1B GRIK3 CLSTN2 GRM2 GRM3 SHISA9 FARP1 LRP2 LTBP1 FUBP3 HTT	4.92e-04	860	108	13	GO:0097447
GeneOntologyCellularComponent	postsynaptic specialization membrane	GRIK3 CLSTN2 CSMD2 SHISA9 CELSR3 AFDN	6.22e-04	201	108	6	GO:0099634
GeneOntologyCellularComponent	postsynapse	PSD ANK1 ANK3 ANKS1B GRIK3 CLSTN2 GRM2 CSMD2 GRM3 SHISA9 CELSR3 FARP1 AFDN HTT	7.55e-04	1018	108	14	GO:0098794
GeneOntologyCellularComponent	spectrin-associated cytoskeleton	ANK1 ANK3	9.30e-04	9	108	2	GO:0014731
GeneOntologyCellularComponent	glutamatergic synapse	ANKS1B GRIK3 CLSTN2 GRM2 CSMD2 GRM3 SHISA9 CELSR3 ACAN FARP1 CDH6 HTT	1.05e-03	817	108	12	GO:0098978
Domain	HABP4_PAI-RBP1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	2.82e-22	16	101	11	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	2.82e-22	16	101	11	IPR006861
Domain	USP_CS	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	2.46e-17	66	101	13	IPR018200
Domain	USP_1	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	5.60e-17	70	101	13	PS00972
Domain	UCH	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.83e-17	71	101	13	PF00443
Domain	USP_2	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.83e-17	71	101	13	PS00973
Domain	USP_3	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	8.30e-17	72	101	13	PS50235
Domain	USP_dom	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	8.30e-17	72	101	13	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	8.30e-17	72	101	13	IPR001394
Domain	zf-C2H2_6	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZNF699 ZNF841 ZNF282 ZFP2	7.78e-06	314	101	10	PF13912
Domain	Tet_JBP	TET2 TET1	2.90e-05	2	101	2	PF12851
Domain	2OGFeDO_noxygenase_dom	TET2 TET1	2.90e-05	2	101	2	IPR024779
Domain	Tet_JBP	TET2 TET1	2.90e-05	2	101	2	SM01333
Domain	Znf_C2H2-like	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 TRAFD1 ZNF827 SF3A3 ZNF841 ZNF282 ZFP2	9.55e-05	796	101	14	IPR015880
Domain	Znf_C2H2	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 TRAFD1 ZNF827 SF3A3 ZNF841 ZNF282 ZFP2	1.08e-04	805	101	14	IPR007087
Domain	ZnF_C2H2	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 TRAFD1 ZNF827 SF3A3 ZNF841 ZNF282 ZFP2	1.12e-04	808	101	14	SM00355
Domain	Lys_sp_deMease-like_dom	KDM5C KDM5D	1.73e-04	4	101	2	IPR013637
Domain	PLU-1	KDM5C KDM5D	1.73e-04	4	101	2	PF08429
Domain	JmjC	KDM5C KDM5D KDM6A	2.86e-04	24	101	3	PF02373
Domain	zf-C5HC2	KDM5C KDM5D	2.86e-04	5	101	2	PF02928
Domain	Znf_C5HC2	KDM5C KDM5D	2.86e-04	5	101	2	IPR004198
Domain	-	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	2.99e-04	679	101	12	3.30.160.60
Domain	zf-C2H2	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	3.60e-04	693	101	12	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	3.65e-04	694	101	12	IPR013087
Domain	JMJC	KDM5C KDM5D KDM6A	6.79e-04	32	101	3	PS51184
Domain	JmjC_dom	KDM5C KDM5D KDM6A	6.79e-04	32	101	3	IPR003347
Domain	JmjC	KDM5C KDM5D KDM6A	7.44e-04	33	101	3	SM00558
Domain	GPCR_3_mtglu_rcpt	GRM2 GRM3	7.94e-04	8	101	2	IPR000162
Domain	ZINC_FINGER_C2H2_2	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	9.65e-04	775	101	12	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	9.87e-04	777	101	12	PS00028
Domain	ZU5	ANK1 ANK3	1.02e-03	9	101	2	SM00218
Domain	ANF_lig-bd_rcpt	GRIK3 GRM2 GRM3	1.04e-03	37	101	3	IPR001828
Domain	ANF_receptor	GRIK3 GRM2 GRM3	1.04e-03	37	101	3	PF01094
Domain	Peripla_BP_I	GRIK3 GRM2 GRM3	1.22e-03	39	101	3	IPR028082
Domain	JmjN	KDM5C KDM5D	1.27e-03	10	101	2	SM00545
Domain	JMJN	KDM5C KDM5D	1.27e-03	10	101	2	PS51183
Domain	ZU5	ANK1 ANK3	1.27e-03	10	101	2	PS51145
Domain	Ank_3	ANK1 ANK3	1.27e-03	10	101	2	PF13606
Domain	JmjN	KDM5C KDM5D	1.27e-03	10	101	2	PF02375
Domain	JmjN	KDM5C KDM5D	1.27e-03	10	101	2	IPR003349
Domain	ZU5	ANK1 ANK3	1.84e-03	12	101	2	PF00791
Domain	ZU5_dom	ANK1 ANK3	1.84e-03	12	101	2	IPR000906
Domain	NCD3G	GRM2 GRM3	2.17e-03	13	101	2	PF07562
Domain	GPCR_3_9-Cys_dom	GRM2 GRM3	2.17e-03	13	101	2	IPR011500
Domain	GPCR_3_CS	GRM2 GRM3	2.53e-03	14	101	2	IPR017979
Domain	-	KDM5C KDM5D	2.90e-03	15	101	2	1.10.150.60
Domain	BRIGHT	KDM5C KDM5D	2.90e-03	15	101	2	SM00501
Domain	ARID_dom	KDM5C KDM5D	2.90e-03	15	101	2	IPR001606
Domain	ARID	KDM5C KDM5D	2.90e-03	15	101	2	PS51011
Domain	ARID	KDM5C KDM5D	2.90e-03	15	101	2	PF01388
Domain	PLAC	ADAMTS12 ADAMTS7	4.66e-03	19	101	2	PS50900
Domain	PLAC	ADAMTS12 ADAMTS7	4.66e-03	19	101	2	IPR010909
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.03e-19	45	82	13	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.28e-12	191	82	14	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.08e-11	221	82	14	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.96e-10	262	82	14	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP30 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.66e-09	299	82	14	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.38e-08	318	82	13	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP30 SP100 ANK1 USP17L12 ANK3 USP17L20 USP17L11 USP17L24 OBSL1 USP17L5 USP17L10 USP17L19 USP17L18 ADAMTS12 ADAMTS7 USP17L17 NCOA1 LTBP1 USP17L22 USP17L15 PCSK9 USP17L13	7.13e-06	1475	82	23	M19806
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP30 SP100 ANK1 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 ADAMTS12 ADAMTS7 USP17L17 USP17L6P NCOA1 LTBP1 USP17L22 USP17L15 PCSK9 USP17L13	3.20e-05	1389	82	21	MM15307
Pathway	REACTOME_HDMS_DEMETHYLATE_HISTONES	KDM5C KDM5D KDM6A	6.21e-04	29	82	3	MM14934
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.03e-28	21	110	13	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	7.38e-28	22	110	13	9154835
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.30e-27	33	110	14	20228807
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.69e-27	24	110	13	8995226
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	20403174
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	20388806
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	14699124
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	20368735
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	11941478
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.60e-27	34	110	14	21448158
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	7.66e-27	25	110	13	21115691
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	9.32e-27	35	110	14	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	9.32e-27	35	110	14	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.52e-26	36	110	14	20147298
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.53e-26	26	110	13	35816173
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.44e-26	37	110	14	20228808
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	9.89e-26	29	110	13	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.90e-22	50	110	13	31806660
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	TET2 USP17L21 ANK1 USP17L12 USP17L20 USP17L11 GATA2 ZNF521 USP17L5 USP17L10 USP17L19 MAGEA13P USP17L18 USP17L17 USP17L6P USP17L22 KDM6A USP17L15 USP17L13	4.19e-13	674	110	19	37196079
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	1.09e-07	119	110	7	28625976
Pubmed	X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.	KDM5C KDM5D KDM6A	1.23e-07	4	110	3	32732223
Pubmed	PROSER1 mediates TET2 O-GlcNAcylation to regulate DNA demethylation on UTX-dependent enhancers and CpG islands.	TET2 TET1 KDM6A	3.06e-07	5	110	3	34667079
Pubmed	DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism.	TET2 ACAN TET1	1.70e-06	8	110	3	28614801
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SHLD2 FLNB ERCC4 ANK3 FLYWCH1 ZNF569 DHX38 ZNF429 ZNF699 FARP1 TET1 LRP2 MTO1 FUBP3 D2HGDH	1.71e-06	1084	110	15	11544199
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	KDM5C KDM5D KDM6A	8.60e-06	13	110	3	14660691
Pubmed	Selective silencing of individual dendritic branches by an mGlu2-activated potassium conductance in dentate gyrus granule cells.	GRM2 GRM3	9.91e-06	2	110	2	23616537
Pubmed	Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases.	TET2 TET1	9.91e-06	2	110	2	27362828
Pubmed	Activation of metabotropic glutamate receptor type 2/3 supports the involvement of the hippocampal mossy fiber pathway on contextual fear memory consolidation.	GRM2 GRM3	9.91e-06	2	110	2	19638469
Pubmed	Enhancement of CA3 hippocampal network activity by activation of group II metabotropic glutamate receptors.	GRM2 GRM3	9.91e-06	2	110	2	21628565
Pubmed	Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.	GRM2 GRM3	9.91e-06	2	110	2	30939596
Pubmed	Structural insight into substrate preference for TET-mediated oxidation.	TET2 TET1	9.91e-06	2	110	2	26524525
Pubmed	Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.	TET2 TET1	9.91e-06	2	110	2	30045709
Pubmed	Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.	TET2 TET1	9.91e-06	2	110	2	23415914
Pubmed	Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice.	GRM2 GRM3	9.91e-06	2	110	2	24053122
Pubmed	Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice.	GRM2 GRM3	9.91e-06	2	110	2	38969501
Pubmed	The X-linked histone demethylases KDM5C and KDM6A as regulators of T cell-driven autoimmunity in the central nervous system.	KDM5C KDM6A	9.91e-06	2	110	2	37657612
Pubmed	Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.	GRM2 GRM3	9.91e-06	2	110	2	25583490
Pubmed	The mGluR2/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior.	GRM2 GRM3	9.91e-06	2	110	2	23624743
Pubmed	Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice.	TET2 TET1	9.91e-06	2	110	2	30540950
Pubmed	The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.	GRM2 GRM3	9.91e-06	2	110	2	17670976
Pubmed	Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light.	GRM2 GRM3	9.91e-06	2	110	2	25950516
Pubmed	The effect of mGlu2/3 receptors on synaptic activities to different types of GABAergic interneurons in the anterior cingulate cortex.	GRM2 GRM3	9.91e-06	2	110	2	32525061
Pubmed	Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.	GRM2 GRM3	9.91e-06	2	110	2	19386277
Pubmed	Expression and subcellular distribution of glutamate receptor subunits 2/3 in the developing cerebellar cortex.	GRM2 GRM3	9.91e-06	2	110	2	8838577
Pubmed	Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation.	TET2 TET1	9.91e-06	2	110	2	32114381
Pubmed	TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.	TET2 GATA2	9.91e-06	2	110	2	37794021
Pubmed	Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.	TET2 TET1	9.91e-06	2	110	2	35955629
Pubmed	The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells.	GRM2 GRM3	9.91e-06	2	110	2	7965099
Pubmed	Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.	KDM5C KDM5D	9.91e-06	2	110	2	10441747
Pubmed	Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.	GRM2 GRM3	9.91e-06	2	110	2	34330748
Pubmed	Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.	GRM2 GRM3	9.91e-06	2	110	2	25434487
Pubmed	NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.	GRM2 GRM3	9.91e-06	2	110	2	28285415
Pubmed	Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.	GRM2 GRM3	9.91e-06	2	110	2	24080311
Pubmed	Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.	KDM5C KDM5D	9.91e-06	2	110	2	16416087
Pubmed	mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.	GRM2 GRM3	9.91e-06	2	110	2	34090896
Pubmed	Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism.	TET2 TET1	9.91e-06	2	110	2	24214992
Pubmed	Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.	TET2 TET1	9.91e-06	2	110	2	24474761
Pubmed	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	TET2 TET1	9.91e-06	2	110	2	33926529
Pubmed	Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.	TET2 TET1	9.91e-06	2	110	2	24672749
Pubmed	Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.	GRM2 GRM3	9.91e-06	2	110	2	22089319
Pubmed	A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands.	TET2 TET1	9.91e-06	2	110	2	27288448
Pubmed	Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.	TET2 TET1	9.91e-06	2	110	2	30606231
Pubmed	Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.	KDM5C KDM5D	9.91e-06	2	110	2	32081420
Pubmed	The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis.	ADAMTS12 ADAMTS7	9.91e-06	2	110	2	19098927
Pubmed	Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.	TET2 TET1	9.91e-06	2	110	2	34165552
Pubmed	Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area.	GRM2 GRM3	9.91e-06	2	110	2	21881873
Pubmed	Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.	TET2 TET1	9.91e-06	2	110	2	26598602
Pubmed	Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition.	GRM2 GRM3	9.91e-06	2	110	2	21832989
Pubmed	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	TET2 TET1	9.91e-06	2	110	2	26586431
Pubmed	Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.	ZNF423 UBR5	9.91e-06	2	110	2	23878065
Pubmed	The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-/-), GRM3(-/-) and GRM2/3(-/-) knockout mice.	GRM2 GRM3	9.91e-06	2	110	2	25158312
Pubmed	Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.	TET2 TET1	9.91e-06	2	110	2	35075236
Pubmed	Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.	KDM5C KDM5D	9.91e-06	2	110	2	9060413
Pubmed	Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells.	TET2 TET1	9.91e-06	2	110	2	26328763
Pubmed	Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.	TET2 TET1	9.91e-06	2	110	2	27778125
Pubmed	Genome-wide association study of copy number variants suggests LTBP1 and FGD4 are important for alcohol drinking.	FGD4 LTBP1	9.91e-06	2	110	2	22295116
Pubmed	Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.	GRM2 GRM3	9.91e-06	2	110	2	27911756
Pubmed	Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.	GRM2 GRM3	9.91e-06	2	110	2	23392308
Pubmed	Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.	GRM2 GRM3	9.91e-06	2	110	2	20970439
Pubmed	TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells.	TET2 TET1	9.91e-06	2	110	2	27863519
Pubmed	Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.	GRM2 GRM3	9.91e-06	2	110	2	18720515
Pubmed	Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome.	LRP2 PCSK9	9.91e-06	2	110	2	37406929
Pubmed	Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice.	GRM2 GRM3	9.91e-06	2	110	2	34217776
Pubmed	Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.	TET2 TET1	9.91e-06	2	110	2	28783731
Pubmed	Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.	TET2 TET1	9.91e-06	2	110	2	28252217
Pubmed	Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein.	ZNF423 ZNF521	9.91e-06	2	110	2	12393497
Pubmed	Metabotropic glutamate receptor 2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, and of rats and mice after pilocarpine-induced status epilepticus.	GRM2 GRM3	9.91e-06	2	110	2	15246118
Pubmed	Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.	GRM2 GRM3	9.91e-06	2	110	2	18853337
Pubmed	Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.	GRM2 GRM3	9.91e-06	2	110	2	21057775
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.65e-25	79	110	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 ZNF141 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 HTT USP17L13	6.02e-21	222	110	17	chr4p16
Cytoband	16p13.12	ERCC4 SHISA9	2.53e-04	10	110	2	16p13.12
Cytoband	1p34.3	GRIK3 CSMD2 SF3A3	4.57e-04	62	110	3	1p34.3
Cytoband	10q21	ANK3 TET1	6.68e-04	16	110	2	10q21
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF141 ZBTB48 ZNF569 ZNF423 ZNF429 ZNF521 ZFPM1 ZNF699 ZNF827 ZNF841 ZNF282 ZFP2	2.09e-05	718	71	12	28
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5C KDM5D KDM6A	1.11e-04	24	71	3	485
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM2 GRM3	4.19e-04	8	71	2	281
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR2 CSMD2 ACAN	1.46e-03	57	71	3	1179
GeneFamily	AT-rich interaction domain containing	KDM5C KDM5D	1.54e-03	15	71	2	418
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS12 ADAMTS7	2.49e-03	19	71	2	50
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.47e-17	86	106	13	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.83e-16	112	106	13	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L12 ANK3 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.65e-15	160	106	14	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 RIPK4 USP17L19 ZNF699 USP17L18 TRAFD1 ADAMTS7 USP17L17 USP17L6P NCOA1 HSD17B4 USP17L22 USP17L15 USP17L13	1.33e-11	647	106	19	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 FLT1 USP17L12 USP17L20 USP17L11 USP17L5 ZCCHC17 USP17L10 USP17L19 USP17L18 SHISA9 ACSL4 CELSR3 USP17L17 FARP1 USP17L6P AFDN USP17L22 AJUBA KDM6A USP17L15 USP17L13 CKMT1A	3.64e-10	1198	106	23	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 SP100 USP17L12 USP17L20 USP17L11 POLR2A USP17L5 USP17L10 RIPK4 USP17L19 ZNF699 USP17L18 TRAFD1 ADAMTS7 USP17L17 USP17L6P NCOA1 HSD17B4 USP17L22 USP17L15 USP17L13	1.77e-08	1226	106	21	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L12 USP17L20 USP17L11 KDM5C USP17L5 USP17L10 USP17L19 USP17L18 ACSL4 USP17L17 USP17L6P MTO1 USP17L22 KDM6A USP17L15 USP17L13	1.39e-06	1072	106	17	MM1031
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FLNB ANK1 CLSTN2 ADAMTS12 ACAN LTBP1 CDH6	1.90e-07	181	101	7	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ZNF827 FGD4 FARP1 LRP2 AFDN CDH6	3.04e-07	194	101	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	Neuronal-Excitatory-eD(FEZF2)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 GRIK3 CLSTN2 GRM3 ADAMTS12 AFDN CDH6	3.73e-07	200	101	7	1b485ff2435c6732be58cbc9eb2f5c273f9c4bf2
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CHAD GRIK3 CSMD2 SHISA9 FGD4 CDH6	3.72e-06	182	101	6	f7f9be9c7ef8da9864d6aefe20043b26e1bb8697
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB FLT1 ZNF423 ZNF521 LTBP1 LTF	4.21e-06	186	101	6	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	facs-Lung-EPCAM-18m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CHAD RIPK4 ZNF827 AJUBA CKMT1A	4.62e-06	189	101	6	783c1db856f2defe6f3b8748dd0bc29a8102f6d1
ToppCell	facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CHAD RIPK4 ZNF827 AJUBA CKMT1A	4.62e-06	189	101	6	88b72fafbe58463543e0818f27f3dd9e5b4d34d2
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMPRSS13 CHAD RIPK4 ZNF827 AJUBA CKMT1A	4.76e-06	190	101	6	47e07ea22733306d8885ee9e5f0b033e2f5e2afb
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMPRSS13 CHAD RIPK4 ZNF827 AJUBA CKMT1A	4.76e-06	190	101	6	261b8afddfdcba4f70b50df126cef7ad00a0aae0
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TMPRSS13 RIPK4 SHISA9 FRY FGD4 LRP2	5.36e-06	194	101	6	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD FRY ACAN FARP1 LOXL4 KLC3	5.86e-06	197	101	6	6e111ba16fc8adde782b3f7da250248cddf11228
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 LTBP1 LTF	6.39e-06	200	101	6	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 CD177 CFAP65 LTF CKMT1A	1.32e-05	133	101	5	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 CD177 CFAP65 LTF CKMT1A	1.32e-05	133	101	5	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	Children_(3_yrs)-Immune-enucleated_erythrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 NPIPB15 ANK1 ZNF423 SELENON	4.06e-05	168	101	5	8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKS1B GRIK3 SHISA9 ACSL4 LTBP1	4.17e-05	169	101	5	2456b3e7776e8a2214972be1b4d66a3ca5480ae0
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ATP8B3 ZNF521 ADAMTS12 ADAMTS7 ZFP2	4.54e-05	172	101	5	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	wk_20-22-Epithelial-PNS\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GRIK3 CLSTN2 CSMD2 SHISA9 CDH6	4.66e-05	173	101	5	17b1a6b0318925d5d920f2c0a791745b9587ebef
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKS1B CHAD GRIK3 SHISA9 CDH6	4.79e-05	174	101	5	412ccc099028a372b9d953363984c2da54b2187f
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP30 FLT1 FLYWCH1 GPRIN3 TOP3B	5.06e-05	176	101	5	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD ACAN LOXL4 CDH6 KLC3	5.06e-05	176	101	5	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 FLT1 CD177 GATA2 LTF	5.06e-05	176	101	5	9ddf87e586d2378984cd007c60f7dc254845f8f3
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 FLT1 CD177 GATA2 LTF	5.06e-05	176	101	5	e987e741fcf1bed8598a5060700efd3018f8123b
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 FLT1 CD177 GATA2 LTF	5.06e-05	176	101	5	92ebcea9b2b22601234b76d7a98f0410b905a87b
ToppCell	wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CD177 HEATR5A GRIK3 SHISA9 CDH6	5.20e-05	177	101	5	15a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GRIK3 SHISA9 FGD4 LRP2 CDH6	5.20e-05	177	101	5	59726bfd98f656fdcedf448a7e2e76a9bfad8285
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMPRSS13 RIPK4 LTF KLC3 CKMT1A	5.34e-05	178	101	5	b89c4d015b44bf538aa39969ef8778877c8023f1
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMPRSS13 RIPK4 LTF KLC3 CKMT1A	5.34e-05	178	101	5	fb8f8d95f6b08378fb42c4076ee040276faa296f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GPRIN3 GRIK3 CLSTN2 LRRK1 ADAMTS12	5.48e-05	179	101	5	c815eb9f760fe4ca7a5e49beb224659f0b864f22
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GPRIN3 GRIK3 CLSTN2 LRRK1 ADAMTS12	5.48e-05	179	101	5	53e700494d251ec5649b2dea5fc7d5aeeeed572b
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN2 WFDC8 ADAMTS12 AJUBA CDH6	5.48e-05	179	101	5	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN2 ADAMTS12 ACSL4 FRY FARP1	5.48e-05	179	101	5	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN2 WFDC8 ADAMTS12 AJUBA CDH6	5.48e-05	179	101	5	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	5.63e-05	180	101	5	8923a42a6db9c6e9f3ce2ca9530e620dfea700ba
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIK3 CSMD2 SHISA9 FGD4 CDH6	5.78e-05	181	101	5	fad7ba168f541ac9d04edebc206f191e48bb7e99
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLYWCH1 CD177 ZFPM1 ADAMTS7 LTF	5.93e-05	182	101	5	52eac2f892ea7f26731e0b21c578fd2665a1657a
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GRIK3 CSMD2 SHISA9 FGD4 CDH6	5.93e-05	182	101	5	b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 GPRIN3 GRIK3 ADAMTS7 KLC3	5.93e-05	182	101	5	6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SHISA9 FARP1 LRP2 LTF CDH6	6.09e-05	183	101	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	SP100 FLT1 ZNF423 ZNF521 C1orf21	6.09e-05	183	101	5	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANK1 GATA2 LTBP1 CDH6 KLC3	6.09e-05	183	101	5	1db466cf757813322db1cdcc0bf1d91c062fd9de
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KDM5C SELENON ADAMTS12 FARP1 PCSK9	6.09e-05	183	101	5	91079a11685dd466bd27a0cf5afbf3734c08a05e
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 RIPK4 AJUBA KLC3 CKMT1A	6.09e-05	183	101	5	ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CHAD GRIK3 SHISA9 FGD4 CDH6	6.09e-05	183	101	5	f517215ff45dec914af52dfdbc4579c19654c3aa
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT1 GATA2 ZNF521 C1orf21 LTBP1	6.09e-05	183	101	5	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 RIPK4 AJUBA KLC3 CKMT1A	6.09e-05	183	101	5	f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FLT1 CD177 GATA2 AFDN	6.41e-05	185	101	5	c3105978d971da7d0fad1a717ee29afee5ed6357
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FLT1 CD177 GATA2 AFDN	6.41e-05	185	101	5	4cfef50aeed5b3000ce5e864a41c13740b8267b1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 GRIK3 WFDC8 ADAMTS12 ACAN	6.41e-05	185	101	5	e87e6e097dc29ece8aea671935bde281b99b93ea
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIK3 CSMD2 SHISA9 FGD4 CDH6	6.41e-05	185	101	5	56c7a0dbf141728ac76b8c90af197719942ca67c
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FLT1 CD177 GATA2 AFDN	6.41e-05	185	101	5	09256c6f42f59b7eb89160b2ea706172a5b743be
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GRIK3 CSMD2 SHISA9 FGD4 CDH6	6.41e-05	185	101	5	a8946379fc066903fe8f4bc9cbf693b7b424a0cd
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB FLT1 LRRK1 FGD4 LTBP1	6.57e-05	186	101	5	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 ADAMTS12 MB21D2 C1orf21 CDH6	6.57e-05	186	101	5	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CLSTN2 MB21D2 FARP1 LRP2 CDH6	6.74e-05	187	101	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 DHX38 SHISA9 LRP2 NCOA1	6.74e-05	187	101	5	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 GPRIN3 FRY MB21D2 AFDN	6.91e-05	188	101	5	3e3055dacc05a932f2beb114babf1dc76994e1af
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANK3 RIPK4 FRY FGD4 LRP2	7.09e-05	189	101	5	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 AFDN LTBP1 LTF CKMT1A	7.09e-05	189	101	5	27e5d706f10a6221f314faf642eede15deab3165
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CLSTN2 MB21D2 FARP1 LRP2 CDH6	7.27e-05	190	101	5	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	SP100 KDM5D ADAMTS12 NCOA1 AFDN	7.27e-05	190	101	5	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAD GPRIN3 RIPK4 ACAN CKMT1A	7.45e-05	191	101	5	116fba9badea093e11f370996247cca0e4c02e8f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLSTN2 MB21D2 FARP1 LRP2 CDH6	7.45e-05	191	101	5	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ATXN7L1 FGD4 FARP1 LRP2	7.64e-05	192	101	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB FLT1 ZNF423 ZNF521 AFDN	7.82e-05	193	101	5	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 FGD4 FARP1 LRP2 AFDN	7.82e-05	193	101	5	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 TMPRSS13 RIPK4 KLC3 CKMT1A	7.82e-05	193	101	5	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	facs-Trachea-nan-3m-Epithelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CLSTN2 RIPK4 LRP2 CKMT1A	8.02e-05	194	101	5	3701ca87c6dc9ccd7b4146e56371546174d26c36
ToppCell	facs-Trachea-nan-3m-Epithelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CLSTN2 RIPK4 LRP2 CKMT1A	8.02e-05	194	101	5	65f9bf126be26114c2c3f4c46d48318986212a92
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZNF423 ANKS1B ZNF521 ADAMTS12 FARP1	8.02e-05	194	101	5	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 CLSTN2 LRP2 LOXL4 CDH6	8.02e-05	194	101	5	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB FLT1 ZNF423 ZNF521 AFDN	8.02e-05	194	101	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 CD177 GPRIN3 GRIK3 FARP1	8.02e-05	194	101	5	1bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RIPK4 SHISA9 FRY FGD4 LRP2	8.02e-05	194	101	5	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ZNF423 ANKS1B ZNF521 ADAMTS12 FARP1	8.21e-05	195	101	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GRIK3 CSMD2 SHISA9 FGD4 CDH6	8.41e-05	196	101	5	9afd0a7135028a446f06bb68f334e79b8f171b45
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD FRY ACAN FARP1 LOXL4	8.62e-05	197	101	5	4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD FRY ACAN FARP1 LOXL4	8.62e-05	197	101	5	ece0c17eb68f394b20e588c0b0626d3987a4dbbb
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 UBR5 FGD4 NCOA1 KDM6A	9.04e-05	199	101	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNB FLT1 ZNF521 UBR5 AFDN	9.25e-05	200	101	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 FRY	9.25e-05	200	101	5	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	Neuronal-Excitatory-eG(DAPK2)-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	9.25e-05	200	101	5	7cea58e2691564e653cc972bf5aaff2df1f2666e
ToppCell	Neuronal-Excitatory-eG(DAPK2)--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	9.25e-05	200	101	5	193c42c31a366a60d80c4c1fc6a1592a5b01a3ad
ToppCell	Neuronal-Excitatory-eG(DAPK2)---\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	9.25e-05	200	101	5	7c780e995a5fc3793080da61b6bf7a12880e9df8
ToppCell	Neuronal-Excitatory-eG(DAPK2)----L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	9.25e-05	200	101	5	d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	HEATR5A RIPK4 ZNF827 FARP1 AFDN	9.25e-05	200	101	5	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Neuronal-Excitatory-eG(DAPK2)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GPRIN3 CLSTN2 LRRK1 GRM3 ADAMTS12	9.25e-05	200	101	5	8444ae3c10b1152dec67ca812e6c417cc3b9cf89
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 AFDN LTBP1	9.25e-05	200	101	5	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CD177 GATA2 ACSL4 LTF HSD17B4	9.25e-05	200	101	5	cad2d972aa6ea0cc9ebe5ec60fda6e306e9ee2b2
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 GATA2 ZNF521 FRY AFDN	9.25e-05	200	101	5	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 ZNF521 AFDN	9.25e-05	200	101	5	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 FRY LTBP1	9.25e-05	200	101	5	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNB FLT1 GATA2 AFDN LTBP1	9.25e-05	200	101	5	b1ff8d61b567f85006d6d20093f9c803b6d34674
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.01e-24	46	104	14	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P LRP2 USP17L22 USP17L15 USP17L13	2.72e-23	69	104	15	DOID:1682 (implicated_via_orthology)
Disease	Addicted to cocaine	GRM2 GRM3	3.68e-05	3	104	2	C0858355
Disease	syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)	KDM5C KDM5D	7.35e-05	4	104	2	DOID:0060809 (implicated_via_orthology)
Disease	Myelodysplastic syndrome	TET2 GATA2	1.22e-04	5	104	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	TET2 GATA2	1.22e-04	5	104	2	614286
Disease	Leukemia, Myelomonocytic, Chronic	TET2 KDM6A	1.83e-04	6	104	2	C0023480
Disease	internet addiction disorder	FLNB ANK1 GRM3	2.15e-04	33	104	3	EFO_0803368
Disease	response to anticonvulsant	ZNF521 CLSTN2 LOXL4 CDH6	2.37e-04	85	104	4	GO_0036277
Disease	Schizophrenia	PSD ANK3 GRIK3 GRM2 CSMD2 GRM3 CFAP65 ADAMTS12 TET1 LRP2 TOP3B	2.87e-04	883	104	11	C0036341
Disease	sleep duration, low density lipoprotein cholesterol measurement	DHX38 ZNF827 HTT PCSK9	3.08e-04	91	104	4	EFO_0004611, EFO_0005271
Disease	cognitive function measurement	ERCC4 TMPRSS13 FLYWCH1 POLR2A ZNF521 CLSTN2 GRM3 SHISA9 C1orf21 FGD4 FARP1 LOXL4 LTBP1 AJUBA	5.10e-04	1434	104	14	EFO_0008354
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	ERCC4 ANKS1B GRIK3 GRM3 SHISA9	7.27e-04	200	104	5	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	angina pectoris	FLT1 DHX38 ADAMTS7 PCSK9	1.02e-03	125	104	4	EFO_0003913
Disease	forced expiratory volume, response to bronchodilator	TET2 SP100 FLYWCH1 GPRIN3 CLSTN2 ADAMTS7 FGD4	1.02e-03	445	104	7	EFO_0004314, GO_0097366
Disease	revision of total hip arthroplasty	RIPK4 ADAMTS12	1.09e-03	14	104	2	EFO_0020973
Disease	Proteinuria	ADAMTS7 LRP2	1.25e-03	15	104	2	HP_0000093
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5C KDM5D	1.43e-03	16	104	2	DOID:0050888 (implicated_via_orthology)
Disease	MYELODYSPLASTIC SYNDROME	TET2 ERCC4 GATA2	1.73e-03	67	104	3	C3463824
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 FLT1 KDM5C KDM6A	1.89e-03	148	104	4	C0279702
Disease	neuroticism measurement, wellbeing measurement, depressive symptom measurement	SHISA9 FARP1	2.02e-03	19	104	2	EFO_0007006, EFO_0007660, EFO_0007869
Disease	unipolar depression, bipolar disorder	ERCC4 ANK3 GRIK3 SHISA9	2.29e-03	156	104	4	EFO_0003761, MONDO_0004985
Disease	Disproportionate short stature	FLNB OBSL1 ACAN	2.58e-03	77	104	3	C0878659
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM2 GRM3	2.97e-03	23	104	2	C0393672
Disease	Epilepsy, Lateral Temporal	GRM2 GRM3	2.97e-03	23	104	2	C0393682
Disease	frailty measurement	ANK3 HTT	2.97e-03	23	104	2	EFO_0009885
Disease	Uncinate Epilepsy	GRM2 GRM3	2.97e-03	23	104	2	C0014558
Disease	Epilepsy, Temporal Lobe	GRM2 GRM3	2.97e-03	23	104	2	C0014556
Disease	coronary artery disease	TET2 FLT1 RNLS DHX38 ZFPM1 DMXL1 ADAMTS7 ZNF827 FARP1 SF3A3 PCSK9	3.27e-03	1194	104	11	EFO_0001645

Protein segments in the cluster

Peptide	Gene	Start	Entry
QPHHCDLTNMDGVVT	AFDN	446	P55196
HHSNLIAGMTGQCER	ACSL4	291	O60488
LQGHAHISCMPGTVR	CSMD2	1941	Q7Z408
LVGHSMAICTRHPQG	CSMD2	2501	Q7Z408
HGCHMQRLNARQPPA	AJUBA	521	Q96IF1
QTPLHCAARIGHTNM	ANK1	471	P16157
ALHNMHRALCPNTTR	GRM2	391	Q14416
AHALHKMQRTLCPNT	GRM3	401	Q14832
QGTVTCEAPNSRMHH	ATP8B3	301	O60423
CHRGTTIMTHGNLAQ	CD177	211	Q8N6Q3
FRAMPNLVSLHLQHC	CHAD	71	O15335
IHPSHIAMQLTVGAC	CLSTN2	486	Q9H4D0
VSELCSLNINMHHDP	DMXL1	1756	Q9Y485
PQVFQSHCERRHGSM	ATXN7L1	111	Q9ULK2
LGLSHLSGMCQPHRS	ADAMTS12	361	P58397
TLGLSHVAGMCQPHR	ADAMTS7	356	Q9UKP4
HVAGMCQPHRSCSIN	ADAMTS7	361	Q9UKP4
ISAHPNLMSCNTRKH	ANKS1B	181	Q7Z6G8
ICQSSSGHMHALVLP	OBSL1	471	O75147
IHQVTCLGTEPHMAN	LOXL4	246	Q96JB6
NQPVTLDMRHSALCH	MB21D2	131	Q8IYB1
QEASMLHALQHPCIV	LRRK1	1306	Q38SD2
MECNGAISAHHNLPL	MTO1	386	Q9Y2Z2
QGHRIMVMRSHCHQP	FLYWCH1	646	Q4VC44
GKARMTLHCAFQPTH	CFAP65	521	Q6ZU64
GLPNHVHQMTADAVC	KDM6A	746	O15550
LMSHGVPVVRTNQCA	KDM5D	566	Q9BY66
NSHCVRFVPQEMGVH	FLNB	2151	O75369
PAEASMGTRVHCHQQ	PCSK9	541	Q8NBP7
GRQCMHPLSVHLTKQ	LTBP1	686	Q14766
CGSLTLQHHMLEPVQ	FGD4	336	Q96M96
HPTKSHSFRAMCQNG	CFHR2	246	P36980
AQVMGPPDRCQHAAH	FUBP3	301	Q96I24
HLVTNHMVCQPGSKG	ZFPM1	366	Q8IX07
SGHCHPDVATMLNIL	KLC3	241	Q6P597
GGHRRMLAQHCVDAN	LRP2	3301	P98164
RMAAAEHRHSSGLPC	NPIPB15	216	A6NHN6
MPHSQKSRHCELEQG	MAGEA13P	1	A6NCF6
VQRHMPTIRCQPSGH	ACAN	2481	P16112
HARLTGGQMCRPHLL	GATA2	76	P23769
RVNVHSPHRAMAALG	HTT	2906	P42858
ISCLQQLHMFAPRHV	HEATR5A	1046	Q86XA9
ERQAPHRGNTMVHVC	FARP1	901	Q9Y4F1
NIHCNTIAPNAGSRM	HSD17B4	186	P51659
GLVHQPRANMHISES	C1orf21	81	Q9H246
SPLHMATQGDHLNCV	ANK3	336	Q12955
NMQSCHAEALIHPTG	CDH6	596	P55285
HGLQHGSQIPCIQMA	FAM172BP	131	A6NC97
AMVANLIQCVPVHHR	FRY	1096	Q5TBA9
DCQLTMAHPHHFRGN	CELSR3	1756	Q9NYQ7
PQMTVNSLQCHRHKA	GRIK3	341	Q13003
LIHTPLTMPANQHTC	GPRIN3	121	Q6ZVF9
DPNAQCLRHGFMLHT	DCAF15	206	Q66K64
VCMQLVGRHLHLASP	D2HGDH	316	Q8N465
LRKHNNCMASHLTPA	CKMT1A	56	P12532
CSAHNMLPHLERIQV	TIGD6	286	Q17RP2
NTDLHGHNIGKRMTC	PSD	661	A5PKW4
RSCHLAMAPNHAVVS	LTF	606	P02788
TIHEIHCQRNIGMCP	TRAFD1	26	O14545
NSHTFNCRMLIHPPD	NCOA1	191	Q15788
PDLSGHFLANCMNRH	SHLD2	71	Q86V20
PQGHCNTDHMERDLN	SHISA9	196	B4DS77
GQIPEENMSLCHARH	SPATA31C1	1066	P0DKV0
RTPMHVACQHGQENI	RIPK4	586	P57078
LVRQRTGHHCPTAVM	TET1	1501	Q8NFU7
HPSCQHSLSMLGIGQ	TOP3B	711	O95985
CGHRASSRNGLQMHI	ZBTB48	441	P10074
NMHLRTHTGEKPFQC	ZBTB48	481	P10074
MLPVRHGNCNHEAQR	WFDC8	96	Q8IUA0
QEARLRCSPMKGHSH	TRBV18	36	A0A087X0M5
HPACLPMHGQTFSLN	TMPRSS13	431	Q9BYE2
PGCRKQGLVHRTHMS	ZCCHC17	36	Q9NP64
AAANCPGQMTLHHKP	RNLS	296	Q5VYX0
TCRGHLMAITRHGVN	POLR2A	1406	P24928
HCQMHPDLRNSLTGF	ZNF521	1006	Q96K83
THRIQMPSGLCAHLF	SERINC4	91	A6NH21
MICLPNGTVVHHINA	SELENON	526	Q9NZV5
CISPVANEMNHLPAH	SP100	16	P23497
CTMQAHITRALHNPG	USP17L18	126	D6R9N7
RPCLPTAQACTMSHH	FAM90A2P	366	Q658T7
CTMQAHITRALHNPG	USP17L5	126	A8MUK1
CTMQAHITRALHNPG	USP17L21	126	D6R901
CTMQAHITRALHNPG	USP17L13	126	C9JLJ4
SLTCRNHALHMPRGE	PPP1R3D	276	O95685
CTMQAHITRALHNPG	USP17L19	126	D6RCP7
VNIRTGMPCHLHPTS	DHX38	1091	Q92620
MHRTCTDHAPLAIAQ	UNQ9370/PRO34162	26	Q6UXP9
VARPPAMCSHFTQDH	ZNF141	71	Q15928
RHMVIHTGLKSHQCP	ZNF827	391	Q17R98
SCLARHQRMHTGEKP	ZNF841	466	Q6ZN19
CTMQAHITRALHNPG	USP17L12	126	C9JPN9
QCSLLNLHMRSHTGE	ZNF569	561	Q5MCW4
CTMQAHITRALHNPG	USP17L24	126	Q0WX57
KIHRMGVVAHACNPS	ZNF429	641	Q86V71
QRHEMVANPSVLCSH	ZNF66	66	Q6ZN08
QHPFHGRLTSNMVCK	USP30	221	Q70CQ3
HAHGMRCLGIPNTAH	SF3A3	431	Q12874
PGVNAKNCRSLMHHV	ERCC4	856	Q92889
HCQMHPDLRNSLTGF	ZNF423	1006	Q2M1K9
SIPMVKRPHNCNSHG	ZFP2	66	Q6ZN57
CTMQAHITRALHNPG	USP17L6P	126	Q6QN14
LTGRTMHCHLDAPAN	WDR24	16	Q96S15
NCPSSLSIHMRKHTG	ZNF699	401	Q32M78
CTMQAHITRALHNPG	USP17L22	126	D6RA61
HIMQAGQTLHLQCRG	FLT1	41	P17948
QQPQTESCHSQMHRP	TET2	966	Q6N021
CTMQAHITRALHNPG	USP17L15	126	C9J2P7
CTMQAHITRALHNPG	USP17L17	126	D6RBQ6
CTMQAHITRALHNPG	USP17L23	126	D6RBM5
NCHSGLIRHQMTHRG	ZNF282	556	Q9UDV7
CTMQAHITRALHNPG	USP17L20	126	D6RJB6
NHFGRRCATTPMAVH	UBR5	2261	O95071
CTMQAHITRALHIPG	USP17L10	126	C9JJH3
CTMQAHITRALHNPG	USP17L11	126	C9JVI0
MSHSRRAAPTQDQCH	nan	1	Q96M85
LMSHGVPVVRTNQCA	KDM5C	576	P41229